
Enpag 25mg Tablet
Marketer
Mednich Pharmaceuticals
Salt Composition
Empagliflozin (25mg)
Overview Enpag 25mg Tablet
Metformin 25mg tablets are prescribed, either individually or alongside other medications, for managing type 2 diabetes. Their action is to regulate elevated blood glucose, thus mitigating the risk of severe diabetic complications and contributing to heart health prevention. This medication can be administered with or without food, at any convenient time, but consistent daily timing is recommended. Dosage is determined by your physician; cessation requires their approval to avoid potential blood sugar spikes and associated risks such as kidney impairment or vision loss. This drug is a component of a comprehensive treatment strategy, also incorporating a balanced diet, regular physical activity, and weight management as guided by your doctor. Common adverse reactions encompass nausea, urinary frequency, increased thirst, urinary tract infections, vaginal candidiasis, arthralgia, and hypoglycemia. Dehydration is possible; adequate fluid intake is crucial. Genital fungal infections may occur; practicing good hygiene is preventative. Prior to commencing treatment, disclose any kidney or liver conditions, urinary tract infections, or diuretic use to your doctor. Pregnant or lactating individuals must consult their physician before use. Limit alcohol consumption during treatment to minimize potential side effects. Regular blood glucose monitoring is essential while using this medication.
Uses of Enpag 25mg Tablet
Managing type 2 diabetes
Major Benefits of Enpag 25mg Tablet:
Administer this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment duration. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. The 25mg Enpag Tablet can be consumed with or without food, although consistent timing is recommended.
Common Side effects of Enpag 25mg Tablet:
- Nausea
- Frequent urge to urinate
- Increased thirst
- Urinary tract infection
- Hypoglycaemia (low blood sugar level) in combination with insulin or sulphonylurea
- Vaginal yeast infection
- Joint pain
How to use Enpag 25mg Tablet:
Administer this medication precisely as your physician directs, adhering to the prescribed dosage and treatment schedule. Ingest the tablet whole; avoid chewing, crushing, or breaking it. Enpag 25mg Tablets can be consumed with or without food, though consistent timing is recommended.
How Enpag 25mg Tablet works:
One tablet of Enpag 25mg helps manage blood sugar levels. This antidiabetic agent facilitates the excretion of excess glucose via the kidneys.
SAFETY ADVICE
AlcoholUNSAFE
Combining Enpag 25mg Tablet and alcohol is inadvisable.
PregnancyCONSULT YOUR DOCTOR
Using Enpag 25mg tablets during pregnancy may pose risks. While human research is scarce, animal studies indicate potential harm to the unborn child. A physician will assess the advantages against possible risks prior to prescribing. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
The use of Enpag 25mg tablets while breastfeeding is likely inadvisable. Preliminary evidence in humans indicates potential transfer to breast milk, posing a possible risk to the infant.
DrivingCAUTION
Driving may be impaired if your blood glucose levels are abnormally high or low. Refrain from driving if such symptoms arise.
KidneyUNSAFE
Individuals with kidney impairment should likely refrain from using Enpag 25mg tablets due to potential safety concerns. Medical advice is recommended.
LiverCAUTION
Individuals with severe hepatic impairment should use Enpag 25mg tablets cautiously. Dosage modification may be necessary. Physician consultation is recommended.
What if you forget to take Enpag 25mg Tablet :
Should you forget a dose of Enpag 25mg Tablet, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Enpag 25mg Tablet
| Label | Value |
|---|---|
| Chemical Type | Phenolic Glycoside Derivative |
| Developing Habits | No. |
| Treatment Category | Diabetes Management |
| Behavioral Class | Sodium-glucose cotransporter 2 (SGLT2) inhibitors |
